Altogether, these results suggested that FBLN2 exerted a promoting effect to facilitate HCC cell proliferation, which was mediated via regulation of the Ras-MEK-ERK1/2 signaling cascade. Here, MAP2K7 is linked to hepatocellular carcinoma.